-
Everyone is marketing to try and predict and of course in healthcare this is prevalent too and “why they market their ass off”. Tracking and snooping is part of marketing if you have not figured that out yet today. In the video below even ABC has finally come out to state how insurance tracks...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Feb 28 2011
Filed under:
Filed under: Medically Related, Insurance, My Commentaries, EMR, drugs, privacy, EHR, Pharma, PHR, Prescriptions, data bases, Business Intelligence, Data Mining, personal health record, Algorithms, formulas, CCleaner, Flash cookies, do not track
-
She does make some very good points here with bringing in additional revenue to allow the FDA to inspect more over seas manufacturing facilities. She also states that branded companies as well as generic drug companies both need need more attention with inspections. Currently in the US factories...
-
This is something new I have not seen in genomic research to put various patents out on the market for bid. You can read through the press release and see the descriptions for the patents going up for the highest bidder. This is in the area of the lab-on-a-chip area. Wikipedia offers...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Feb 16 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, DNA, Genomics, Pharma, Research and Development, Brokers, Intellectual property, microarray, technologies, auctions, Biochips, ICAP, lab-on-a-chip
-
This acquisition has been in the news since I believe last August with board rejections and now it appears it has finally resolved and Genzyme will be purchased by Sanofi. This is a huge price tag at $20 Billion. You may or may not be familiar with Genzyme but back in 2009 they were in the...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Feb 16 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Biotech, Massachusetts, Mergers and Acquisitions, Sanofi-Aventis, Genzyme, research and development collaboration
-
Sales have fallen and I guess even that big reward from Boston Scientific for 2 billion in 2010 was not enough to keep things rolling along here. Apparently the stent business is growing in other places and sales are down to 2.5 billion from 4 billion just a few years ago. Other companies...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Feb 10 2011
Filed under:
Filed under: Medically Related, Technology, drugs, healthcare, Medical Devices, Pharma, Biotech, FDA, Stents, Recalls, Legal Suits, Investments, Boston Scientific, Johnson and Johson, Cordis
-
If you have been a reader here long enough at the Quack then you have probably read one of my articles about the use of bar codes on drugs and medical devices. We have somewhat of a step in this direction, but lots of lack luster still missing. You can read the short paragraph below and see...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Feb 7 2011
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, Tracking, Pharma, FDA, cell phones, Safety, information, Scanning, Bar Codes, MDs, adverising, FadeMark
-
This is very cool if you have trademarks or are wanting to file one for sure. I can’t help but think in the pharma end of healthcare that Trademarkia will perhaps be used quite a bit. All the trademarks issued in the US since 1870 claim to be listed. I just went to the general page...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Feb 4 2011
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, Social Networks, Pharma, Intelligence, Algorithms, websites, business, trademarks, Trademarkia, logos, US Patent and Trademark Office
-
Patrick Soon-Shiong M.D. is the Los Angeles billionaire investor who has scooped up the company. Overall the product is a good thing as far as the reminder system and keep folks on track. My only concerns is the privacy factors and the data that it creates for sale. In today’s world...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Feb 4 2011
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, EMR, drugs, healthcare, EHR, Pharma, PHR, Prescriptions, data bases, Business Intelligence, Fines, personal health record, Algorithms, formulas, Express Scripts, overcharges, Vitality, Cobert Report, nsurance
-
This is a game or situation that Johnson and Johnson seems to be good at with their multitude of legal cases with stents. This time they are on the losing end of the stick with a jury ruling they violated a patent. The same researcher also won a case against Boston Scientific on his design...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sat, Jan 29 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Medical Devices, Pharma, Biotech, FDA, Stents, Recalls, Legal Suits, Investments, Boston Scientific, Johnson and Johson
-
It doesn’t get much more upfront than this with one mentioning their feelings on how the company is being run does it. The one quote below is interesting too in the fact that “everything is under control”? How come we have more recalls coming up all the time? As soon as one fire is...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Jan 27 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, healthcare, Investors, Pharma, FDA, Johnson and Johnson, Recalls, Wall Street, McNeil Consumer Healthcare, Bill Weldeon
-
The cuts amount to around 2% of the workforce. The company has also had their share of recalls and the glucose strips were huge and again states the need for a way of consumers, doctors and pharmacists to identify them. Abbott Diabetes Care Recalls Tons of Glucose Test Strips–The US Has the...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Jan 27 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Pharma, FDA, Abbott, weight loss, obesity, Recalls, Drug Safety, women's health, Beauty, jobs, Food Safety and Recalls
-
Well the patients in the US have to wait a little longer and it is amazing that in Europe as the title suggests has generics available. In May of 2010 Plavix was given a ruling by the FDA to establish a black box warning too. FDA Gives Plavix New Box Warning Relating to Metabolization in...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Jan 26 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Pharma, Pills, FDA, Generic Drugs, Marketing, Patents, Europe, Plavix, Sanofi-Aventis, expire, Bristol-Myers Squibb
-
This is good news for allergy sufferers. The over the counter availability will begin in March 2011. It will be the same strength that is currently only available via a prescription. BD Sanofi-Aventis U.S., and its U.S. Consumer Healthcare Division, Chattem, Inc., announced today...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Jan 26 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Pharma, Pills, allergies, over the counter, nasal congestion, sinus, Sanofi-Aventis. FDA, Allegra
-
Just a couple weeks ago, Amgen contracted with Boehringer Ingelheim to take over their Fremont, California location so all employees will now report to Boehringer Ingelheim, which has it headquarters in Germany. BioVex is working on a new approach to treating melanoma and head and neck cancer and...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Jan 25 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Pharma, Biotech, Cancer, clinical trials, Amgen, Vaccine, Mergers and Acquisitions, stock, transactions, head cancer, melinoma, BioVex, biotechnology
-
Vilazodone is a modulator of serotonin neurotransmission to be used for treatment of Major Depression Disorders. Now there’s one more choice for depression, it’s amazing if you look how many of these are out there. BD From the website: “Nearly 2,900 patients have been exposed to vilazodone...